Refine Results
- Products
- Applications and Industries
- Content Type
- Analysis Platform
- Language
- Publication Date
121 - 132 of 132 results
This application note introduces a workflow that uses the XF Real-Time ATP rate assay data for identifying metabolic modulator and drug targets.
Learn about a customized workflow to standardize the identification/investigation of mitochondrial toxicity using Agilent Seahorse XF technology.
This application note describes an imaging-based approach to measure changes in cAMP levels over time in live cells.
| Korean (Korea) | Complete (PDF) |
|---|---|
| Japanese (Japan) | Complete (PDF) |
| Chinese (Traditional) (Taiwan) | Complete (PDF) |
The new Agilent BioTek Cytation 9 cell imaging multimode reader represents the next generation of integrated analysis.
Cytation Cell Imaging Multi-Mode Readers combine automated digital microscopy and conventional microplate detection in a modular, upgradable platform. This patented design provides rich phenotypic cellular information with well-based intensity data.
Streamlining Image-Based Neurotoxicity Studies with an Automated Platform for Viability and Neurite Outgrowth Analysis
Many multimode microplate readers use monochromator-based optics for fluorescence intensity measurements, allowing great flexibility to use multiple fluorescent dyes and stains. Most of these systems offer a fixed bandwidth. This offering works well...
Take a look at images captured by Agilent customers using the Lionheart Automated Microscopes, and Cytation Cell Imaging Multimode Readers for their own research.
Poster presented at ADA 2025 featuring the Agilent Seahorse XF Flex analyzer in an optimized workflow to assess metabolic profile during adipocyte differentiation and in adipocyte tissue
DiscoveryBioMed, Inc., supplies products and services to help the drug discovery community improve attrition rates and pinpoint compounds that are high-value clinical candidates. Since its founding in 2007 by physiologist Dr. Erik Schwiebert, this...